PITTSBURGH - The West Penn Allegheny Health System, Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology has established an affiliation with The Cleveland Clinic Foundation, a Parent institution in the Gynecologic Oncology Group (GOG). 

The affiliation gives female reproductive cancer patients at West Penn Hospital local access to some of the national clinical trials sponsored by the GOG.

The GOG receives support from the National Cancer Institute to promote excellence in research in the field of gynecologic malignancies by maintaining the highest standards in clinical trial development and execution.

“We are pleased to be able to offer these cutting edge clinical trials to our patients,” said Dr John Comerci, Director of the Division of Gynecologic Oncology in the Department of Obstetrics and Gynecology, West Penn Allegheny Health System, and principal investigator for the GOG. “Our selection as an affiliate of The Cleveland Clinic speaks to the quality of care delivered to patients treated within the West Penn Allegheny Health System (WPAHS),” added Dr Comerci.

The first trials at WPAHS are expected to begin this fall and involve Avastin, an antiangiogenic agent active in ovarian cancer, as well as a trial investigating intraperitoneal carboplatin and Taxol in the treatment of ovarian carcinoma.

The West Penn Allegheny Health System, Division of Gynecologic Oncology is dedicated to bringing gynecologic oncology services and access to state of the art clinical trials to the community with offices in Sharon, Johnstown, Upper St Clair, Canonsburg and Monroeville.

For additional information, contact the West Penn Hospital Division of Gynecological Oncology at 412-578-5534.